spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  DeCIDe 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 22 Dec 2025
U.S. FDA Approves JASCAYD(R) (nerandomilast) Tablets for the Treatment of Progressive Pulmonary Fibrosis in Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Sep 2025
Mallinckrodt Names Dr. Marek J. Honczarenko as EVP and Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Aug 2025
Mallinckrodt Names Christiana Stamoulis as President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Oct 2024
Lilly's EBGLYSS(TM) (lebrikizumab-lbkz) Demonstrated Meaningful Improvement in Skin Clearance and Itch Relief in the Majority of Patients with Moderate-To-Severe Atopic Dermatitis Who Discontinued Dupilumab
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 18 Oct 2024
CHMP Maintains Negative Opinion on Translarna(TM) Reexamination
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 1 Jul 2024
RaySearch releases RayStation 2024B
Devices Oncology Product Launch
 HSMN NewsFeed - 31 May 2024
SIFI Receives Positive CHMP Opinion for Akantior(R) (polihexanide 0.08%) in Acanthamoeba Keratitis
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 24 May 2024
YS Biopharma Announces Name Change to LakeShore Biopharma
Biopharmaceuticals
 HSMN NewsFeed - 31 Oct 2023
FDA Approves Novartis Cosentyx(R) as the First New Biologic Treatment Option for Hidradenitis Suppurativa Patients in Nearly a Decade
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Sep 2023
Protalix BioTherapeutics Appoints Eliot Richard Forster, Ph.D. as Chairman of its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Sep 2023
First Patient with NyokAssist(TM) Interventional Ventricular Assist Device: Dr. Junbo Ge's team successfully completed the first high-risk PCI treatment supported by the new generation of interventional VAD
Devices Interventional Cardiology
 HSMN NewsFeed - 10 Jul 2023
RayCare in clinical use with CyberKnife at Lausanne University Hospital (CHUV) in Switzerland
Devices Oncology
 HSMN NewsFeed - 24 Apr 2023
Lilly to Divest BAQSIMI to Amphastar
Biopharmaceuticals Endocrinology Mergers & Acquisitions
 HSMN NewsFeed - 14 Apr 2023
Soligenix Provides Regulatory Update on HyBryte(TM)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 30 Nov 2022
Aeglea BioTherapeutics Appoints Jeffrey M. Goldberg as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Sep 2022
Dr. Seth Blacksburg Joins Accuray as VP, Chief Medical Officer Americas Region
Devices Oncology Personnel
 HSMN NewsFeed - 8 Jul 2022
LASEROPTEK Co. Ltd., and Monarch Lasers Sign a Multi-Year Exclusive Distribution Agreement for the United States Medical Aesthetic Market
Devices Dermatology Distribution
 HSMN NewsFeed - 24 May 2022
Recruiting Tips: Why Independent Rep Searches Are Different
Devices Biopharmaceuticals Diagnostics Distribution
 HSMN NewsFeed - 20 Apr 2022
AbbVie terminates collaboration with BioArctic on alpha-synuclein portfolio
Biopharmaceuticals
 HSMN NewsFeed - 31 Jan 2022
Pfizer and Alex Therapeutics announce a Strategic Commercial Partnership to provide evidence-based Digital Therapeutics to patients, starting in Germany
Biopharmaceuticals
 HSMN NewsFeed - 14 Dec 2021
Medtronic INVOS(TM) 7100 Cerebral/Somatic Oximetry System receives 510(k) clearance for pediatric indications
Devices Monitoring FDA
 HSMN NewsFeed - 22 Nov 2021
Board Member Michael Martino to Become Interim Chairman and CEO of Ampio Pharmaceuticals, Mike Macaluso to Take Medical Leave
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Oct 2021
FDA Expands Approval of Dupixent(R) (dupilumab) to Include Children Aged 6 to 11 Years with Moderate-to-severe Asthma
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Sep 2021
Theravance Biopharma, Inc. Announces Strategic Actions to Focus on Respiratory Disease Portfolio
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jun 2021
Interventional Systems Receives FDA Clearance for its All-around Miniature Medical Robot
Devices Interventional FDA
 HSMN NewsFeed - 8 Mar 2021
Abbott Introduces NeuroSphere(TM) Virtual Clinic, First-of-its-Kind Remote Neuromodulation Patient-Care Technology in the U.S.
Devices Neurology Product Launch
 HSMN NewsFeed - 2 Feb 2021
Novel Embolic Device Used for Arterial and Venous Tumor Treatments
Devices Interventional
 HSMN NewsFeed - 15 Oct 2020
Titan Pharmaceuticals Provides a Strategic & Corporate Update
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Sep 2020
NanoVibronix UroShield(R) Receives U.S. Food and Drug Administration Authorization for Entry into the U.S.
Devices FDA
 HSMN NewsFeed - 15 Sep 2020
Mylan and Pfizer Receive European Commission Approval for Proposed Combination of Mylan and Upjohn
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 8 Sep 2020
Mylan to Acquire Aspen's Thrombosis Business in Europe
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 26 Jun 2020
Janssen Announces Discontinuation of Phase 3 LOTUS Study Evaluating Ustekinumab in Systemic Lupus Erythematosus
Biopharmaceuticals
 HSMN NewsFeed - 19 Jun 2020
Dupixent(R) (dupilumab) Approved in China for Adults with Moderate-to-Severe Atopic Dermatitis
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 11 Jun 2020
MolecuLight Announces CMS has Assigned an APC Reimbursement Code for its MolecuLight i:X(R) Procedure for Bacterial Imaging using Fluorescence
Devices Wound Care Reimbursement
 HSMN NewsFeed - 4 Jun 2020
MedHub AutocathFFR Awarded AMAR Certification, Israel's Medical Device Regulatory Approval
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 15 May 2020
Soligenix Announces Recent Accomplishments And First Quarter 2020 Financial Results
Biopharmaceuticals
 HSMN NewsFeed - 29 Apr 2020
Medical Diagnostic Laboratories, L.L.C., Launches Serological Test for Coronavirus Disease 2019 (COVID-19) Antibodies in Human Serum
Diagnostics Product Launch
 HSMN NewsFeed - 23 Mar 2020
Lilly Provides Update on Clinical Trial Activities During COVID-19 Pandemic
Biopharmaceuticals
 HSMN NewsFeed - 23 Mar 2020
Accelerated Road to Market Approval for CERAMENT(R) G in the US - BONESUPPORT(TM) Submits De Novo Application
Devices Orthopaedic Drug Delivery FDA
 HSMN NewsFeed - 27 Feb 2020
Mylan and Pfizer Announce Appointment of Viatris Chief Financial Officer
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 23 Dec 2019
European Medicines Agency Validates BioMarin's Marketing Authorization Application for Valoctocogene Roxaparvovec to Treat Severe Hemophilia A
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 Dec 2019
Pfizer and Mylan Announce Two Future Viatris Board Members
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 9 Dec 2019
PDL BioPharma Announces Completion of Strategic Review Process
Biopharmaceuticals
 HSMN NewsFeed - 2 Oct 2019
Upsher-Smith Laboratories Launches Tosymra(TM) (sumatriptan) Nasal Spray For The Acute Treatment Of Migraine In Adults
Biopharmaceuticals Neurology Drug Delivery Product Launch
 HSMN NewsFeed - 8 Aug 2019
Bayer Acquires Bluerock Therapeutics to Build Leading Position in Cell Therapy
Regenerative Medicine Mergers & Acquisitions
 HSMN NewsFeed - 6 Aug 2019
Dupixent(R) (dupilumab) Approved by European Commission for Adolescents with Moderate-to-Severe Atopic Dermatitis
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 2 Aug 2019
InMed Pharmaceuticals Appoints Bruce S. Colwill, CPA, CA as Chief Financial Officer and Announces other Leadership Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jul 2019
Mylan and Upjohn, a Division of Pfizer, to Combine, Creating a New Champion for Global Health Uniquely Positioned to Fulfill the World's Need for Medicine
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Jul 2019
Statement from Mylan's Board of Directors Regarding Retirement of CEO and Board Member Heather Bresch in Conjunction with the Combination of Mylan and Upjohn, a Division of Pfizer
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 15 Jul 2019
Kymera Therapeutics Announces Leadership Transitions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jul 2019
Neovasc to Explore HDE Approval Pathway and Alternate Trial Designs for the Reducer Following Guidance from the FDA
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 24 May 2019
Lannett Announces CFO Retirement
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 7 May 2019
Dupixent(R) (dupilumab) Approved for Severe Asthma by European Commission
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 6 May 2019
Portage Announces Change of CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Apr 2019
United Therapeutics Announces BEAT Study of Esuberaprost Does Not Meet Primary Endpoint
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 2 Apr 2019
Dr. Gustavo Mahler Resigns as Chief Executive Officer of AGC Biologics, Patricio Massera to Succeed as CEO Effective May 1st, 2019
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Mar 2019
The Oklahoma Proton Center, USA, Selects RayStation as its Treatment Planning System
Devices Oncology
 HSMN NewsFeed - 1 Mar 2019
CHMP Recommends Approval of Dupixent(R) (dupilumab) for Asthma Indication
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 28 Feb 2019
Daiichi Sankyo Europe and Esperion Announce Validation of the Marketing Authorisation Application (MAA) for Bempedoic Acid and the Bempedoic Acid / Ezetimibe Fixed Dose Combination Tablet
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 5 Dec 2018
Bausch & Lomb Receives 510(K) Clearance From FDA For Bausch & Lomb Ultra(R) Multifocal For Astigmatism Contact Lenses
Devices Ophthalmology FDA
 HSMN NewsFeed - 5 Nov 2018
CMS Grants Outpatient Pass-through Payment to the remedē(R) System for the Treatment of Central Sleep Apnea
Devices Neurology Reimbursement
 HSMN NewsFeed - 30 Oct 2018
U.S. FDA Approves INVOKANA(R) (canagliflozin) to Reduce the Risk of Heart Attack, Stroke or Cardiovascular Death in Adults with Type 2 Diabetes and Established Cardiovascular Disease
Biopharmaceuticals Endocrinology Cardiology FDA
 HSMN NewsFeed - 22 Oct 2018
FDA Approves Asthma Indication for Dupixent(R) (dupilumab)
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Oct 2018
Field Orthopaedics Forms Exclusive Partnership With Ortho Consulting Group to Launch New Micro Screw Into EMEA
Devices Orthopaedic Distribution Product Launch
 HSMN NewsFeed - 1 Oct 2018
Orexo Internalizes Contract Field Force in the US to Further Strengthen the Commercial Organization
Biopharmaceuticals Drug Delivery Distribution
 HSMN NewsFeed - 27 Aug 2018
Janssen Announces Results from MARINER and COMMANDER HF Studies
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 8 Aug 2018
A First in the World of Radiology: Aidoc Receives FDA Clearance to Enable Radiologists to Triage Patients Using AI
Devices Radiology FDA
 HSMN NewsFeed - 30 Jul 2018
Nevro Announces Patent Litigation Update
Devices Neurology Litigation
 HSMN NewsFeed - 18 Jun 2018
Proposed Remetinostat Phase III Design Results in Delay in Planned Start of Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 May 2018
Positive Phase 3 Trial of DUPIXENT(R) (dupilumab) in Adolescents with Inadequately Controlled Moderate-to-severe Atopic Dermatitis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 27 Apr 2018
BD Names Three Executives to Segment Leadership Roles
Devices Personnel
 HSMN NewsFeed - 15 Mar 2018
Ionis and Akcea Partner to Commercialize Inotersen for hATTR
Biopharmaceuticals Licensing
 HSMN NewsFeed - 6 Mar 2018
Corin Group Launches Trinity(TM) Dual Mobility System for Hip Replacement at AAOS 2018 Annual Meeting
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 2 Mar 2018
FDA to Review DUPIXENT(R) (dupilumab) as Potential Treatment for Moderate-to-Severe Asthma
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Feb 2018
Genomic Health Expands Offering to Prostate Cancer Patients with Launch of Oncotype DX(R) AR-V7 Nucleus Detect(TM) Test to Predict Treatment Response in Metastatic Disease
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 25 Jan 2018
IRIS Announces Changes and Additions to Its Executive Leadership Team
Devices Ophthalmology Personnel
 HSMN NewsFeed - 22 Jan 2018
Regeneron Announces Approval of DUPIXENT(R) (dupilumab) in Japan for the Treatment of Atopic Dermatitis
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 16 Jan 2018
Novartis new data reinforces superiority of Cosentyx(R) versus Stelara(R) in achieving skin clearance for psoriasis patients
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 5 Dec 2017
INVOKANA(R) (canagliflozin) Significantly Improved Renal Outcomes and Demonstrated Potential Renal Protective Effects in Patients with Type 2 Diabetes Who Have or Are at Risk for Cardiovascular Disease
Biopharmaceuticals Nephrology
 HSMN NewsFeed - 30 Nov 2017
Mitsubishi Tanabe Pharma America Announces Addition of RADICAVA(R) (edaravone) to U.S. Department of Veterans Affairs National Formulary
Biopharmaceuticals Neurology Reimbursement
 HSMN NewsFeed - 21 Nov 2017
MiMedx Provides Update On Its Reimbursement Coverage
Regenerative Medicine Reimbursement
 HSMN NewsFeed - 21 Nov 2017
Ardelyx Announces Updated Development Path for its Cardiorenal Pipeline
Biopharmaceuticals
 HSMN NewsFeed - 30 Oct 2017
FDA Approves New 10 mg Dosing for XARELTO(R) (rivaroxaban) to Reduce the Continued Risk of Venous Thromboembolism (VTE)
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Oct 2017
Celgene Provides Update on GED-0301 (mongersen) Inflammatory Bowel Disease Program
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 5 Oct 2017
Animas Corporation to Close Operations and Exit Insulin Pump Market
Devices Endocrinology
 HSMN NewsFeed - 28 Sep 2017
Magenta Medical, Developer of Novel Heart Failure Therapies, Secures $15 Million in Series B Financing
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 28 Sep 2017
Regeneron and Sanofi Announce Approval of DUPIXENT(R) (dupilumab) to Treat Adult Patients with Moderate-to-Severe Atopic Dermatitis in the European Union
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 26 Sep 2017
Spiral Therapeutics Receives Positive IND Submission Guidance from FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Sep 2017
Allergan Announces Tessa Hilado, Executive Vice President and Chief Financial Officer, to Retire from Company
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Sep 2017
ManaMed Inc. Introduces PlasmaFlow, The World's First FDA-Approved Digital and Tubeless Deep Vein Thrombosis Prevention Device
Devices Product Launch
 HSMN NewsFeed - 28 Aug 2017
Philips and HeartFlow Announce Global Collaboration Agreement
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Aug 2017
First FDA-Approved Treatment For ALS In 22 Years Now Available In U.S.
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 7 Jul 2017
UK Supreme Court Rules In Lilly's Favor On Alimta Vitamin Regimen Patents
Biopharmaceuticals Litigation
 HSMN NewsFeed - 28 Jun 2017
Philips to acquire Spectranetics for $1.7B
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 6 Jun 2017
100,000th Robotic-Arm Assisted Joint Replacement Procedure Performed in the U.S. with Stryker's Mako System
Devices Orthopaedic
 HSMN NewsFeed - 28 Apr 2017
Teijin to Withdraw from U.S. Home Health Care Business to Complete Business Restructuring
Devices
 HSMN NewsFeed - 28 Apr 2017
Epic Sciences Announces Completion of $40 Million Series D Financing
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 24 Apr 2017
SIR-Spheres(R) Y-90 Resin Microspheres Substantially Improves Quality of Survival in Primary Liver Cancer, New Study Against Standard Treatment Shows
Devices Oncology
 HSMN NewsFeed - 21 Apr 2017
Valeant's Patient Access And Pricing Committee Announces Pricing For SILIQ(TM) (Brodalumab) As The Lowest Priced Injectable Biologic For Moderate-To-Severe Plaque Psoriasis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 10 Apr 2017
Axovant Sciences Announces Appointment of Dr. David Hung as Chief Executive Officer and Expansion of Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 30 Mar 2017
U.S. FDA Approves Addition of Moderate to Severe Fingernail Psoriasis Data to AbbVie's HUMIRA(R) (adalimumab) Prescribing Information
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Mar 2017
Sanofi and Regeneron Announce FDA Approval of Dupixent(R) (dupilumab), the First Targeted Biologic Therapy for Adults with Moderate-to-Severe Atopic Dermatitis
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 24 Jan 2017
FDA Grants Priority Review for Genentech’s Actemra(R) (Tocilizumab) Supplemental Biologics License Application for Giant Cell Arteritis, a Form of Vasculitis
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Jan 2017
Bristol-Myers Squibb Provides Regulatory Update in First-line Lung Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 10 Jan 2017
ZELTIQ Aesthetics, Inc. Announces Commercial Leadership Transition
Devices Dermatology Personnel
 HSMN NewsFeed - 9 Jan 2017
CEO Geoffrey McDonough to Leave Sobi
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jan 2017
GRAIL Plans to Raise in Excess of $1B in Series B Funding
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 16 Dec 2016
Janssen Submits Application Seeking FDA Approval of STELARA(R) (Ustekinumab) for the Treatment of Adolescents with Moderate to Severe Plaque Psoriasis
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 13 Dec 2016
Valeant Appoints William D. Humphries As EVP, Dermatology
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 9 Dec 2016
Biogen and AbbVie Receive Health Canada Approval of Once-Monthly ZINBRYTA(TM) (Daclizumab Beta) for Multiple Sclerosis
Biopharmaceuticals Nerurology Regulatory
 HSMN NewsFeed - 1 Nov 2016
Pfizer Discontinues Global Development of Bococizumab, Its Investigational PCSK9 Inhibitor
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 13 Oct 2016
NeuroVive discontinues development of CicloMulsion for acute kidney injury
Biopharmaceuticals
 HSMN NewsFeed - 5 Oct 2016
FDA Approves Continued Access to ReCell(R) in US Burns Trial
Devices Regenerative Medicine FDA
 HSMN NewsFeed - 28 Sep 2016
Dr. Daniel Alkon Appointed President of Neurotrope, Inc.
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 26 Sep 2016
Pfizer Decides Remaining One Company Best Positions Company To Maximize Future Value Creation
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Sep 2016
Philips Introduces Next Generation Interventional Oncology Solution OncoSuite* for Advanced Tumor Analysis and Therapy in Europe
Devices Interventional Oncology Product Launch
 HSMN NewsFeed - 7 Sep 2016
St. Jude Medical Brings Legal Action Against Muddy Waters and MedSec
Devices Cardiology Litigation
 HSMN NewsFeed - 5 Sep 2016
Dynavax Provides Regulatory Update on HEPLISAV-B
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Sep 2016
Merck Provides Update on Odanacatib Development Program
Biopharmaceuticals
 HSMN NewsFeed - 5 Jul 2016
Recro Pharma Appoints Michael Celano as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Apr 2016
AtriCure Announces 510(k) Clearance for the cryoFORM(TM) Cryoablation Probe
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 5 Apr 2016
Pfizer Announces Positive Top-Line Results from the First Phase 3 Trial of Investigational Tofacitinib in Adults with Psoriatic Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 18 Mar 2016
STELARA(R) Induced Clinical Response And Remission In Phase 3 Study For The Treatment Of Patients With Moderate To Severe Crohn's Disease Who Had Previously Failed Or Were Intolerant To Anti-TNF-Alpha Therapy
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 15 Mar 2016
Lilly Announces Change to Primary Endpoint of EXPEDITION3 Study
Biopharmaceuticals Neurology
 HSMN NewsFeed - 3 Mar 2016
Valeant Pharmaceuticals Comments On Management Change
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 6 Feb 2016
Prism Medical Announces Appointment of Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 27 Jan 2016
MetaCure Announces Appointment of New CEO
Devices Endocrinology Personnel
 HSMN NewsFeed - 11 Jan 2016
Bioventus Board of Managers Appoints Bill Hawkins Chairman
Devices Regenerative Medicine Orthopaedic Personnel
 HSMN NewsFeed - 4 Jan 2016
Padlock Therapeutics Creates West Coast Operations Appointing Scientific Co-founder Kerri Mowen, Ph.D., as Director of Biology Based in San Diego
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Dec 2015
Merck KGaA, Darmstadt, Germany, Decides Not to Pursue Evofosfamide Further in Soft Tissue Sarcoma and Pancreatic Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Dec 2015
vTv Therapeutics Announces Larry Altstiel to Serve As Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Nov 2015
Hi-Tech Pharmaceuticals Files Lawsuit Against IronMag Labs and Robert Dimaggio Over Racketeer Influenced and Corrupt Organizations (RICO) and Patent Infringement
Biopharmaceuticals Litigation
 HSMN NewsFeed - 30 Oct 2015
Mylan Appoints Ranjan Ray Chaudhuri as Global Commercial Lead for Mylan's Over-the-Counter Business
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Sep 2015
Ignyta Appoints Igor Bilinsky as General Manager, Immuno-Oncology and Senior Vice President, Special Operations
Personalized Medicine Oncology Personnel
 HSMN NewsFeed - 14 Sep 2015
Mylan Commences Offer to Acquire Perrigo
Biopharmaceuticals Generic Mergers & Acquisitions
 HSMN NewsFeed - 11 Sep 2015
AbbVie's HUMIRA(R) (Adalimumab) Receives First and Only U.S. Food and Drug Administration Approval for Moderate to Severe Hidradenitis Suppurativa
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 9 Sep 2015
St. Jude Medical Announces Leadership Transition Plan
Devices Cardiology Neurology Personnel
 HSMN NewsFeed - 28 Aug 2015
Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 Jun 2015
ZS Pharma Names Jeffrey Farrow as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Apr 2015
Pain Therapeutics Announces Appointment of Senior Vice President, Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Apr 2015
Lima Corporate Acquires Unicompartmental and Total Knee for European Markets
Devices Orthopaedic Acquisitions
 HSMN NewsFeed - 26 Mar 2015
Sagent Pharmaceuticals Announces Leadership Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Mar 2015
Actavis Receives FDA Approval of SAPHRIS(R) for Pediatric Patients (age 10-17) for Acute Treatment of Manic or Mixed Episodes of Bipolar I Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Mar 2015
Endologix Announces Chief Financial Officer Transition
Devices Interventional Personnel
 HSMN NewsFeed - 6 Mar 2015
Sunshine Heart Provides Update on U.S. Pivotal Study of C-Pulse(R) Heart Assist System
Devices Cardiology
 HSMN NewsFeed - 23 Feb 2015
Nakashima and Teijin to Establish Joint Venture for Global Expansion of Japanese-made Medical Device Business
Devices Orthopaedic Mergers & Acquisitions
 HSMN NewsFeed - 12 Jan 2015
Debiopharm Group(TM) Regains Full Rights to Alisporivir Program
Biopharmaceuticals
 HSMN NewsFeed - 9 Jan 2015
Endo Announces Changes to Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Dec 2014
Tal Medical Appoints Atul Pande, M.D., Former SVP and Head of Neurosciences at GSK, as Chief Medical Officer, EVP and SAB member
Devices Neurology Personnel
 HSMN NewsFeed - 7 Nov 2014
Finding Medical Independent Sales Reps and Saving Money: FindReps USA Updated for iOS 8
Devices Distribution
 HSMN NewsFeed - 5 Nov 2014
U.S. Veterans And Military Gain Access To "Smart" Wound Care Technology
Devices Wound Care Distribution
 HSMN NewsFeed - 29 Sep 2014
Intuitive Surgical Receives FDA Clearance for First Single-Site(R) Wristed Needle Driver for da Vinci(R) Si(R) Surgical System
Devices Surgery FDA
 HSMN NewsFeed - 18 Sep 2014
Evotec Takes Legal Steps Against Andromeda Biotech, Ltd.
Biopharmaceuticals Litigation
 HSMN NewsFeed - 17 Sep 2014
Ivera Medical Files Patent Infringement Case Against Catheter Connections and CTI for Sales of Light Blue DualCap IV Pole Strips
Devices Litigation
 HSMN NewsFeed - 27 Aug 2014
Bellicum Pharmaceuticals Secures $55 Million in Oversubscribed Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Jul 2014
Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction
Biopharmaceuticals Generics Acquisitions
 HSMN NewsFeed - 30 Jun 2014
Flamel Technologies Announces FDA Approval of VAZCULEP
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Jun 2014
Takeda Announces Termination of Orteronel (TAK-700) Development for Prostate Cancer in Japan, U.S.A. and Europe
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 May 2014
Statement from Pfizer Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 14 May 2014
Senior Level Changes at Dr. Reddy’s
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Apr 2014
Pfizer Announces Positive Top-Line Results from Two Phase 3 Trials of Tofacitinib in Adults with Moderate-to-Severe Chronic Plaque Psoriasis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 8 Apr 2014
Fresenius Medical Care Renal Therapies Group Announces Chief Medical Officer to Retire
Devices Personnel
 HSMN NewsFeed - 4 Apr 2014
Statement by the Board of Directors of Meda
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 Mar 2014
Corgenix Board of Directors Announces Exploration of Strategic Alternatives
Diagnostics
 HSMN NewsFeed - 12 Mar 2014
Pfizer Presents Detailed Results From Landmark Community-Acquired Pneumonia Immunization Trial In Adults (CAPiTA) Evaluating Efficacy Of Prevenar 13*
Biopharmaceuticals
 HSMN NewsFeed - 3 Mar 2014
Myriad Publishes Clinical Utility Study for Prolaris(R)
Diagnostics Urology
 HSMN NewsFeed - 26 Feb 2014
SafeOp Surgical Receives FDA Clearance for EPAD(TM) Neuromonitoring Device
Devices Neurology Monitoring FDA
 HSMN NewsFeed - 25 Feb 2014
InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF)
Biopharmaceuticals
 HSMN NewsFeed - 17 Feb 2014
Quest Diagnostics Announces Senior Leadership Appointments
Diagnostics Personnel
 HSMN NewsFeed - 28 Jan 2014
St. Jude Medical Announces Organizational and Executive Leadership Changes
Devices Cardiology Personnel
 HSMN NewsFeed - 27 Jan 2014
Covidien Chief Financial Officer Charles Dockendorff to Retire at End of Year
Devices Personnel
 HSMN NewsFeed - 16 Jan 2014
MEDITE Signs Exclusive Marketing and Distribution Agreement With Medline
Diagnostics Distribution
 HSMN NewsFeed - 15 Jan 2014
Medtronic to Appeal Federal District Court Verdict
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 7 Jan 2014
Bellicum Pharmaceuticals Raises $34.4 Million in a Series B Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 19 Dec 2013
Study Shows Robotic-Assisted Prostate Surgery Reduces Hospital Readmission and Complication Rates Compared to Open Surgery
Devices Surgery Oncology
 HSMN NewsFeed - 10 Dec 2013
Boston Therapeutics Appoints Three to Management Positions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Dec 2013
Shareholders Representing 70% of Outstanding Shares in Pulsion Have Agreed to Accept Getinge's Offer in Intended Acquisition of Pulsion Medical Systems
Devices Monitoring Mergers & Acquisitions
 HSMN NewsFeed - 29 Nov 2013
Osiris Provides Update on Proposed Ruling by CMS
Devices Regenerative Medicine Wound Care Reimbursement
 HSMN NewsFeed - 20 Nov 2013
Vertex Sells INCIVO(R) Product Royalty Rights for $152 Million
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 25 Oct 2013
Elekta appoints Niklas Savander as its next President and Chief Executive Officer
Devices Oncology Neurosurgery Personnel
 HSMN NewsFeed - 24 Oct 2013
Rigel Provides Pipeline Update
Biopharmaceuticals
 HSMN NewsFeed - 22 Oct 2013
Elekta declines to continue to participate in linear accelerator bidding process in Brazil
Devices Oncology
 HSMN NewsFeed - 17 Oct 2013
Pfizer Receives European Approval For Label Update Regarding The Use Of Prevenar 13 In Certain High-Risk Populations
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 1 Oct 2013
Genomic Health Announces Presentation of Oncotype DX(R) Studies Reinforcing Value of Tests in Guiding Treatment for Multiple Cancers
Diagnostics Oncology
 HSMN NewsFeed - 1 Oct 2013
CEO Change for Meda AB
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Sep 2013
DURECT Announces Changes to its Board of Directors
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 25 Sep 2013
RTI Surgical(TM) Announces First Implantation of map3(TM) Cellular Allogeneic Bone Graft in a Foot and Ankle Procedure
Devices Orthopaedic
 HSMN NewsFeed - 30 Aug 2013
EMD Serono President and Head of US Operations James Hoyes Resigns
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Aug 2013
LipoScience Appoints Robert Greczyn Interim President and Chief Executive Officer
Diagnostics Personalized Medicine Personnel
 HSMN NewsFeed - 1 Aug 2013
Artimplant applies for its own bankruptcy
Devices Orthopaedic
 HSMN NewsFeed - 29 Jul 2013
Perrigo Company to Acquire Elan Corporation, plc for US$8.6 Billion, Establishing Premier Global Healthcare Company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Jun 2013
First U.S. Center Treats Patient with the New TomoHDA(TM) System
Devices Oncology
 HSMN NewsFeed - 25 Jun 2013
Multiplicom Appoints Dr. Ian Gilham as Chairman of the Board
Diagnostics Personnel
 HSMN NewsFeed - 17 Jun 2013
InSite Vision Announces Joint Patent Infringement Lawsuit with Merck Against Mylan Pharmaceuticals
Biopharmaceuticals Ophthalmology Generics Litigation
 HSMN NewsFeed - 12 Jun 2013
Mark Sieczkarek Elected Chairman of the Board of Solta Medical
Devices Dermatology Personnel
 HSMN NewsFeed - 29 May 2013
Reorganization of the Corporate Management Structure of Grünenthal Group
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 May 2013
KCI Launches Prevena(TM) Peel & Place(TM) Dressing with V.A.C.(R) Therapy Connector
Devices Surgery Wound Care Product Launch
 HSMN NewsFeed - 17 May 2013
Genentech and Biogen Idec Have Filed for a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case
Biopharmaceuticals Litigation
 HSMN NewsFeed - 10 May 2013
Curis Announces Approval of Erivedge(R) in Australia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 7 May 2013
OrbusNeich enforces injunction against Boston Scientific in Germany
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 23 Apr 2013
Diamyd Medical Changes Name to Mertiva
Biopharmaceuticals
 HSMN NewsFeed - 4 Apr 2013
Aerocrine Passes Regulatory Milestone in Japan
Devices Regulatory
 HSMN NewsFeed - 27 Mar 2013
Bioheart's Appeals to the FDA for Compassionate Use Designation to Save Lives
Regenerative Medicine Cardiology FDA
 HSMN NewsFeed - 11 Mar 2013
invendo medical Announces US Market Entry Following Special 510(k) Clearance By FDA For Computer-Assisted Single-Use Colonoscopy System
Devices Gastroenterology
 HSMN NewsFeed - 11 Mar 2013
Moberg Derma Discontinues Clinical Development of Limtop
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 4 Mar 2013
Larry Cohen Appointed CEO of Exalenz Bioscience
Devices Diagnostics Personnel
 HSMN NewsFeed - 1 Mar 2013
Sucampo Appoints Barbara A. Munder and Maureen E. O’Connell to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Feb 2013
SynCardia Total Artificial Heart Patient with End-Stage Renal Failure Recovers Kidney Function after Two Months of Support
Devices Cardiology
 HSMN NewsFeed - 5 Feb 2013
Orexo strengthens the commercial leadership structure and appoints Nikolaj Sørensen as new CEO and Martin Nicklasson as Executive Chairman
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 4 Feb 2013
JenaValve Appoints John F. Migliazza, Chief Operating Officer
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 20 Dec 2012
Covidien Announces Five-Year Results from the ClosureFast(TM) Long-Term European Multi-Center Study in Patients with Lower Limb Venous Disease
Devices Interventional
 HSMN NewsFeed - 17 Dec 2012
Monteris(R) Medical Announces Appointment of Greg Barrett as Board Chairman
Devices Neurosurgery Personnel
 HSMN NewsFeed - 4 Dec 2012
Endologix Announces CFO Retirement
Devices Interventional Personnel
 HSMN NewsFeed - 29 Nov 2012
Northern Centre for Cancer Care Acquires Two TrueBeam(TM) Devices from Varian Medical Systems to Deliver Advanced Radiosurgery Treatments
Devices Oncology
 HSMN NewsFeed - 27 Nov 2012
Jay Millerhagen Joins Respicardia(R) as Vice President of Clinical Affairs and Market Development
Devices Personnel
 HSMN NewsFeed - 8 Nov 2012
Auspex Pharmaceuticals Closes $25 Million Series D Financing
Biopharmaceuticals Neurology Venture Capital Personnel
 HSMN NewsFeed - 7 Nov 2012
U.S. Food and Drug Administration Approves Pfizer’s XELJANZ(R) (tofacitinib citrate) for Adults with Moderately to Severely Active Rheumatoid Arthritis (RA) Who Have Had an Inadequate Response or Intolerance to Methotrexate
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Nov 2012
Bioniche Life Sciences Inc. Announces Discontinuation of Current Phase III Clinical Trial with Urocidin(TM)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Nov 2012
HealthTronics Launches New Line Of Slimline Cryoprobes For Use With Its Endocare(R) Cryocare(R) Systems
Devices Interventional
 HSMN NewsFeed - 29 Oct 2012
AmerisourceBergen Names Lawrence C. Marsh Chief Strategy Officer and Senior Vice President of New Market Development
Biopharmaceuticals Distribution Personnel
 HSMN NewsFeed - 29 Oct 2012
Spectrum Pharmaceuticals Appoints Industry Veteran, Former Amgen Executive Joseph Turgeon, as Senior Vice President Sales & Commercial Operations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 24 Oct 2012
Abbott's ALK Test is Now Available in Europe as a Companion Diagnostic Test to Aid in Identifying Patients for Targeted Lung Cancer Therapy
Diagnostics Personalized Medicine Oncology
 HSMN NewsFeed - 1 Oct 2012
Stryker Names Kevin A. Lobo as President and Chief Executive Officer
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 21 Sep 2012
Cialis(R) (tadalafil) Tablets Recommended for Approval for the Treatment of the Signs and Symptoms of Benign Prostatic Hyperplasia in the European Union
Biopharmaceuticals Urology Regulatory
 HSMN NewsFeed - 21 Sep 2012
Astex Pharmaceuticals Discontinues Amuvatinib Clinical Development Program
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Sep 2012
Teva Pharmaceutical Announces the Appointment of Professor Itzhak Krinsky as Chairman of Teva Japan and Teva South Korea and Head of Business Development in Asia-Pacific
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Sep 2012
Institut Curie Acquires Four Advanced Radiotherapy Treatment Systems Including Three Varian TrueBeam Devices
Devices Oncology
 HSMN NewsFeed - 24 Aug 2012
Eli Lilly and Company Announces Top-Line Results on Solanezumab Phase 3 Clinical Trials in Patients with Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 9 Aug 2012
Teleflex Introduces New ARROW(R) FlexTip Plus(R) Closed Tip, Multi-Port Epidural Catheter
Devices
 HSMN NewsFeed - 6 Aug 2012
Astellas to Close Urogenix, North Carolina-based Urology Research Facility
Biopharmaceuticals Urology
 HSMN NewsFeed - 18 Jul 2012
University of California San Francisco Medical Center Purchases BSD-2000 Hyperthermia System from BSD Medical
Devices Oncology
 HSMN NewsFeed - 7 Jun 2012
OxThera Resumes Clinical Development of Hyperoxaluria Therapy
Biopharmaceuticals
 HSMN NewsFeed - 5 Jun 2012
Elekta announces changes to its Executive Management
Devices Oncology Personnel
 HSMN NewsFeed - 17 Apr 2012
Abbott Licenses Biomarkers for Use in Differentiating Aggressive from Nonaggressive Prostate Cancer
Diagnostics Personalized Medicine Oncology Licensing
 HSMN NewsFeed - 5 Apr 2012
FDA Decides Teva is Sole First-to-File on Provigil(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 28 Mar 2012
Merck Appoints Michael J. Holston as Chief Ethics and Compliance Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Mar 2012
Bellicum Closes $20 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Mar 2012
Tekmira Files Motion to Dismiss in Patent Infringement Suit
Biopharmaceuticals Litigation
 HSMN NewsFeed - 6 Mar 2012
Vexim Continues Its Development and Sets up in Germany to Directly Market the SpineJack(R) Range
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 23 Feb 2012
MelaFind(R) Results Improve Detection of Melanoma, Study Shows
Devices Dermatology Oncology
 HSMN NewsFeed - 7 Feb 2012
New Study Evaluates Cialis(R) in parallel with Tamsulosin in Men with Signs and Symptoms Suggestive of Benign Prostatic Hyperplasia
Biopharmaceuticals Urology
 HSMN NewsFeed - 30 Jan 2012
Curis Announces FDA Approval of Erivedge(TM) (vismodegib) Capsule as First Treatment for Advanced Basal Cell Carcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 22 Dec 2011
Dr. Rob Koremans to succeed Dr. Gerard van Odijk as President and CEO of Teva Europe
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Dec 2011
Pfizer Broadens and Extends Commitment to Help Prevent Pneumococcal Disease in Infants and Young Children in the World’s Poorest Countries
Biopharmaceuticals
 HSMN NewsFeed - 15 Dec 2011
Cerulean Pharma Closes $15 Million Series D Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 13 Dec 2011
Sotera Wireless Completes $12.2 Million Series D Financing, Signs Agreement with Cerner
Devices Monitoring Venture Capital
 HSMN NewsFeed - 8 Dec 2011
X-spine Announces FDA Clearance of New Spinal Implant System for Treatment of Disk Disease
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 14 Nov 2011
Catalyst Pharmaceutical Partners Appoints Richard P. Rieger as Vice President, Commercial Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Nov 2011
MELA Sciences Announces FDA Approval for MelaFind(R)
Devices Oncology Dermatology FDA
 HSMN NewsFeed - 31 Oct 2011
World-Renowned Cancer Center to Become All-TrueBeam Clinic in Battle Against Cancer
Devices Oncology
 HSMN NewsFeed - 24 Oct 2011
FDA Approves ONFI(TM) (clobazam) for the Adjunctive Treatment of Seizures Associated with Lennox-Gastaut Syndrome in Patients Two Years and Older
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 7 Oct 2011
Cialis(R) for Once Daily Use Now FDA-Approved to Treat Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) and Men With Both Erectile Dysfunction (ED) and Signs and Symptoms of BPH
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Oct 2011
Gilbert Wai Appointed Executive Vice President, Region Asia Pacific, and Member of Elekta’s Executive Committee
Devices Neurosurgery Personnel
 HSMN NewsFeed - 23 Sep 2011
Scott Solano to Depart AngioDynamics
Devices Personnel
 HSMN NewsFeed - 21 Sep 2011
STENTYS Completes Enrollment of APPOSITION III Study for its Self-Apposing Stent to Treat Heart Attacks
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Jul 2011
St. Gallen International Breast Cancer Expert Panel Guidelines Include Oncotype DX(R) as Predictor of Chemotherapy Benefit
Diagnostics Personalized Medicine Oncology
 HSMN NewsFeed - 8 Jul 2011
Phase III Trial of Novartis Drug Afinitor(R) Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
Biopharmaceuticals
 HSMN NewsFeed - 24 Jun 2011
Amsterdam Molecular Therapeutics Receives Opinion on Glybera(R) Marketing Authorisation Application
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 Jun 2011
Smith & Nephew Endoscopy Awarded $85 Million in Patent Infringement Case Against Arthrex, Inc.
Devices Orthopaedic Litigation
 HSMN NewsFeed - 2 Jun 2011
Healthpoint Biotherapeutics Acquires Regranex(R) Gel
Biopharmaceuticals Wound Care Acquisitions
 HSMN NewsFeed - 23 May 2011
FDA Approves INCIVEK(TM) (telaprevir) for People with Hepatitis C
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 May 2011
EMD Serono President and CEO Fereydoun Firouz Resigns
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 May 2011
Abbott's HUMIRA(R) (Adalimumab) Meets Primary Endpoints in Phase III Ulcerative Colitis Study
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 28 Apr 2011
Exactech Announces Full Market Release of the Equinoxe(R) Shoulder Fracture Plate
Devices Orthopaedic
 HSMN NewsFeed - 26 Mar 2011
APP Pharmaceuticals Issues a Nationwide Voluntary Recall of Irinotecan Hydrochloride Injection
Biopharmaceuticals Oncology Product Recall
 HSMN NewsFeed - 24 Mar 2011
FDA Expands Indication for ZOSTAVAX(R), Merck’s Shingles Vaccine, to Include Adults Ages 50 to 59
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Mar 2011
Utah Medical Products, Inc. Acquires Femcare Group Limited
Devices Mergers & Acquisitions
 HSMN NewsFeed - 9 Mar 2011
2011 Surgical Guidelines Recommend Point-of-Care Platelet Reactivity Testing Prior to Surgery
Diagnostics Biopharmaceuticals Surgery Cardiology
 HSMN NewsFeed - 3 Mar 2011
Medipattern and TomTec Complete Teaming Agreement
Devices Radiology
 HSMN NewsFeed - 17 Feb 2011
Orexigen(R) Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Feb 2011
Orthovita Receives FDA Clearance for Vitoss(TM) Bimodal Bone Graft Substitute
Devices Orthopaedic Regenerative Medicine FDA
 HSMN NewsFeed - 18 Jan 2011
SheerVision, Inc. Announces Expansion Plans
Devices Surgery
 HSMN NewsFeed - 9 Dec 2010
Study Shows Novartis Drug Afinitor(R) Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Dec 2010
OrbusNeich Issues Statement on Boston Scientific's Unsuccessful Retaliatory Litigation Efforts in the Netherlands
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 19 Nov 2010
NeurogesX Receives Qutenza(R)-Specific J-Code From Centers for Medicare and Medicaid Services (CMS)
Biopharmaceuticals Drug Delivery Reimbursement
 HSMN NewsFeed - 15 Nov 2010
FDA Approves Eisai’s Halaven(TM) (Eribulin Mesylate) Injection for Treatment of Metastatic Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 3 Nov 2010
Study in NEJM Shows Novartis Drug Afinitor(R) Reduces Size of SEGAs, Benign Brain Tumors Associated with Tuberous Sclerosis
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Oct 2010
Novartis Drug Afinitor(R) Approved by FDA as First Medication for Children and Adults with a Benign Brain Tumor Associated with Tuberous Sclerosis
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 22 Oct 2010
GE Healthcare to Acquire Cancer Diagnostic Company Clarient Inc.
Diagnostics Personalized Medicine Mergers & Acquisitions
 HSMN NewsFeed - 15 Oct 2010
Nicholas L. Teti, Jr. Appointed President and CEO of Suneva Medical
Devices Personnel
 HSMN NewsFeed - 15 Oct 2010
AcuMEMS Announces New Glaucoma Product for Cataract Surgery
Devices Ophthalmology Monitoring
 HSMN NewsFeed - 29 Sep 2010
Mersana Therapeutics Appoints Nicholas Bacopoulos President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Sep 2010
Pyng Medical Corp. Announces Resignation of President and CEO
Devices Personnel
 HSMN NewsFeed - 31 Aug 2010
Swiss Breast Cancer Patient Becomes First in World to Receive Treatment Using Gated RapidArc from Varian Medical Systems
Devices Oncology
 HSMN NewsFeed - 30 Aug 2010
Otonomy Closes $38.5 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Aug 2010
King Pharmaceuticals Appoints Jeffrey Bailey Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Aug 2010
DePuy Orthopaedics Voluntarily Recalls ASR Hip System
Devices Orthopaedic Product Recall
 HSMN NewsFeed - 15 Jul 2010
Sepracor Inc. to Become Sunovion Pharmaceuticals Inc.
Biopharmaceuticals
 HSMN NewsFeed - 12 Jul 2010
Clarient Announces Publication of Mammostrat(R) Breast Cancer Study in Breast Cancer Research
Diagnostics Oncology
 HSMN NewsFeed - 1 Jul 2010
MAQUET Cardiovascular to Distribute INTERGARD Line of Vascular Grafts in United States
Devices Distribution
 HSMN NewsFeed - 25 Jun 2010
Helicos BioSciences Announces Launch of Diagnostics Business
Diagnostics
 HSMN NewsFeed - 21 Jun 2010
Pfizer Prepares for Voluntary Withdrawal of U.S. New Drug Application and for Discontinuation of Commercial Availability of Mylotarg(R)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Jun 2010
Medicis Announces Organizational Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jun 2010
Hemosphere, Inc., Names Patrick Wethington New CEO
Devices Personnel
 HSMN NewsFeed - 8 Jun 2010
Myriad Pharmaceuticals Announces Intent to Focus on Oncology Portfolio
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Jun 2010
Biogen Idec Provides Update on CEO Search and Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jun 2010
Accuray Installs 200th CyberKnife Robotic Radiosurgery System
Devices Oncology
 HSMN NewsFeed - 26 May 2010
Researchers at MD Anderson Show That Positron Emission Mammography (PEM) Helps Evaluate Early Response to Neoadjuvant Chemotherapy
Devices Radiology Oncology
 HSMN NewsFeed - 19 May 2010
NMT Medical Appoints Paul H. Kramer, MD, to Board of Directors
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 18 May 2010
Inverness Medical Innovations to Change Name to Alere
Diagnostics Devices
 HSMN NewsFeed - 6 May 2010
HealthTronics Enters Into Definitive Merger Agreement With Endo Pharmaceuticals
Devices Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Apr 2010
Farley Named President and CEO of Entellus Medical(R)
Devices Personnel
 HSMN NewsFeed - 23 Apr 2010
Teva Provides Update on Generic Protonix(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 9 Apr 2010
CTI Receives Complete Response Letter from the FDA for Pixantrone NDA; CTI to File for Expanded Access for Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 30 Mar 2010
Ethicon Endo-Surgery Announces Receipt of Offer to Purchase Breast Care Business
Devices Acquisitions
 HSMN NewsFeed - 25 Mar 2010
AVI BioPharma Announces Pending Changes to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Mar 2010
King Pharmaceuticals Announces US Department of Justice Settlement
Biopharmaceuticals
 HSMN NewsFeed - 17 Mar 2010
Radiation Breakthrough Gives Breast Cancer Patients Hope in Single Dose
Devices Oncology
 HSMN NewsFeed - 10 Mar 2010
Smith & Nephew Announces Next Steps in Patent Infringement Litigation
Devices Wound Care Litigation
 HSMN NewsFeed - 3 Mar 2010
NMT Medical Appoints John E. Ahern to Board of Directors
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 1 Mar 2010
Astellas Pharma Inc. Offers to Acquire OSI Pharmaceuticals for $52.00 Per Share in Cash
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Feb 2010
Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
Biopharmaceuticals
 HSMN NewsFeed - 1 Feb 2010
Boston Scientific Settles Longstanding Patent Disputes With J&J
Devices Litigation Interventional Cardiology
 HSMN NewsFeed - 29 Jan 2010
FDA Approves Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizures
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 18 Jan 2010
St. Jude Medical Announces Approval and Launch of Neurostimulation System in Japan
Devices Neurology Regulatory
 HSMN NewsFeed - 11 Jan 2010
Alnylam Provides Key Goals and Guidance for Next 12 to 18 Months
Biopharmaceuticals
 HSMN NewsFeed - 2 Dec 2009
LifeCycle Pharma Promotes Dr. William J. Polvino as New President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Dec 2009
Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center
Devices Oncology
 HSMN NewsFeed - 30 Nov 2009
Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease
Biopharmaceuticals Devices Radiology Neurology
 HSMN NewsFeed - 16 Nov 2009
nContact Announces Initiation of Clinical Trials for the Treatment of Atrial Fibrillation in Open-Chest Procedures
Devices Cardiology
 HSMN NewsFeed - 11 Nov 2009
Texas Children's Hospital Achieves Pediatric Cardiology "First," Discharges Teen with Mechanical Heart Assist Device
Devices Cardiology
 HSMN NewsFeed - 10 Nov 2009
500th Patient Receives an INCOR Ventricular Assist Device at the German Heart Institute Berlin
Devices Cardiology
 HSMN NewsFeed - 10 Nov 2009
Ismail Kola joins UCB as Executive Vice President, UCB & President of UCB New Medicines(TM)
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Oct 2009
Cephalon Appoints Bob Repella as Senior Vice President of U.S. Pharmaceutical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Oct 2009
Institute Curie Hospital Purchases Second TomoTherapy(R) Radiation Therapy System
Devices Oncology
 HSMN NewsFeed - 13 Oct 2009
Amarin Announces Changes to Its Board and Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Oct 2009
Electronic Brachytherapy a Viable Option for Intraoperative Radiation Therapy (IORT)
Devices Oncology
 HSMN NewsFeed - 5 Aug 2009
Merck and Schering-Plough Resolve Previously Disclosed Civil Class Action Lawsuits Related to VYTORIN(R) (ezetimibe/simvastatin) and ZETIA(R) (ezetimibe)
Biopharmaceuticals Cardiology Litigation
 HSMN NewsFeed - 5 Aug 2009
Bioniche Announces Resignation of its CFO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jul 2009
Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors
Devices Regenerative Medicine Wound Care
 HSMN NewsFeed - 28 Jul 2009
Akebia Completes $16M Expansion of Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Jul 2009
Eisai and Pfizer Decide not to Appeal NICE Decision and Call for an Expedited Review of Guidance for Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 1 Jul 2009
MMDI Announces Agreement with Novation to Supply the Rebound HRD(R)
Devices Surgery Group Purchasing
 HSMN NewsFeed - 18 Jun 2009
Elekta Provides VMAT and Radiosurgery Solutions for New Jersey Health System
Devices Oncology
 HSMN NewsFeed - 1 Jun 2009
FDA Approves Lamictal(R)XR(TM); An Extended-Release Once-Daily, New Generation Treatment for Epilepsy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 18 May 2009
BSD Receives FDA Humanitarian Use Designation for the BSD-2000 Hyperthermia System
Devices Oncology FDA
 HSMN NewsFeed - 11 May 2009
FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 11 May 2009
Eurand Announces FDA Approval of EUR-1048 (Lamictal(R) ODT(TM)), Co-Developed With GlaxoSmithKline
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 4 May 2009
Covalon Announces Significant Cost Reductions
Devices
 HSMN NewsFeed - 30 Apr 2009
PhotoThera Closes $50 Million Financing, Announces New President and Chief Executive Officer
Devices Neurology Venture Capital Personnel
 HSMN NewsFeed - 24 Apr 2009
BK Medical to Introduce Flex Focus Mobile Ultrasound Scanner at American Urological Association Annual Meeting in Chicago
Devices Urology
 HSMN NewsFeed - 20 Apr 2009
Pharmasset Voluntarily Halts Clinical Studies with Clevudine in Hepatitis B Infected Patients
Biopharmaceuticals
 HSMN NewsFeed - 14 Apr 2009
NMT Medical Appoints Frank Martin Permanent President & CEO
Devices Cardiology Personnel
 HSMN NewsFeed - 1 Apr 2009
Doctors at Henry Ford Health System Treat Ovarian, Prostate, Lung, and Other Forms of Cancer Using Novalis Tx(TM) Platform for Image-Guided Radiosurgery
Devices Oncology
 HSMN NewsFeed - 25 Mar 2009
Smiths Medical Announces Intent to Stop Selling Deltec Cozmo Insulin Pumps
Devices Endocrinology
 HSMN NewsFeed - 24 Mar 2009
Biodel to Submit New Drug Application for VIAject to FDA
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 19 Mar 2009
Occlutech Obtains Favourable Ruling in Proceedings Initiated by AGA Medical
Devices Interventional Litigation
 HSMN NewsFeed - 17 Mar 2009
Oxygen Biotherapeutics, Inc. to Launch Product Line of Oxycyte(R) Gels for the Over-the-Counter Market
Devices Biopharmaceuticals
 HSMN NewsFeed - 16 Mar 2009
Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 12 Mar 2009
Electro-Optical Sciences Announces Additional Data From MelaFind(R) Pivotal Study Presented at American Academy of Dermatology Meeting
Devices Diagnostics Dermatology
 HSMN NewsFeed - 7 Mar 2009
FDA Appeal Decision Indicates that Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Trial
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 3 Mar 2009
Cambridge Heart's Non-Invasive Microvolt T-Wave Alternans Test Accurately Predicts Risk of Sudden Cardiac Arrest, Meta-Analysis Finds
Devices Cardiology Diagnostics
 HSMN NewsFeed - 24 Feb 2009
CHMP delays European Commission decision process to approve ZEVTERA(TM)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 Feb 2009
Bavarian Nordic Updates on Phase I/II Studies With Breast Cancer Vaccine
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Feb 2009
Oridion Receives FDA 510(k) Clearance for Capnostream(TM)20 Monitor With Integrated Pulmonary Index(TM)
Devices FDA
 HSMN NewsFeed - 12 Feb 2009
Results of First Interim Efficacy Analysis for Riquent Phase 3 ASPEN Trial: Continuation of the Trial is Futile
Biopharmaceuticals
 HSMN NewsFeed - 12 Feb 2009
La Jolla Pharmaceutical Company Announces Negative Results of Interim Efficacy Analysis for Riquent Phase 3 ASPEN Trial
Biopharmaceuticals
 HSMN NewsFeed - 11 Feb 2009
JFK Memorial Hospital Announces Availability of Personalized Partial Knee Resurfacing System for Patients
Devices Orthopaedic
 HSMN NewsFeed - 11 Feb 2009
Laurence Debroux Appointed Chief Strategic Officer (CSO)
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Feb 2009
Watson Acknowledges Federal Trade Commission Action Regarding AndroGel Patent Settlement
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 30 Jan 2009
Lilly Announces Senior Leadership Change
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jan 2009
Roche Intends to Commence Tender Offer to Acquire All Shares of Genentech for US$ 86.50 Per Share in Cash
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Jan 2009
Astellas Proposes to Acquire CV Therapeutics for $16 per Share in Cash
Biopharmaceuticals Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 23 Jan 2009
ImClone Systems and Bristol-Myers Squibb Update the Status of Non-Small Cell Lung Cancer Supplemental Biologics Application Submission for ERBITUX(R)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 21 Jan 2009
Akesis Pharmaceuticals Discontinues Sole Clinical Development Program and Announces Intent to File for Chapter 7 Bankruptcy
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 20 Jan 2009
NovaBay (NBY) Appoints Harry F. Hixson, Jr., PhD, Former Amgen President/Chief Operating Officer to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jan 2009
Metabasis Therapeutics Announces Corporate Restructuring and Workforce Reduction
Biopharmaceuticals
 HSMN NewsFeed - 19 Jan 2009
FDA Issues Complete Response Letter for Iclaprim
Biopharmaceuticalas FDA
 HSMN NewsFeed - 19 Jan 2009
Environmental Tectonics Corporation Announces the Sale of Two BARA-MED(R) XD Monoplace Hyperbaric Chambers
Devices
 HSMN NewsFeed - 17 Jan 2009
Addenbrooke’s Hospital to Install Second TomoTherapy(R) Hi·Art(R) Treatment System
Devices Oncology
 HSMN NewsFeed - 6 Jan 2009
German Appeals Court Rules in Favor of AGA Medical in Patent Infringement Lawsuit Against Occlutech
Devices Interventional Litigation
 HSMN NewsFeed - 31 Dec 2008
China Medical Technologies Announces the Completion of the Sale of its HIFU Business
Devices Acquisitions
 HSMN NewsFeed - 16 Dec 2008
Jazz Pharmaceuticals Announces Reduction in Force to Reflect Streamlined Operations
Biopharmaceuticals
 HSMN NewsFeed - 3 Dec 2008
MEDTRONIC STATEMENT
Devices
 HSMN NewsFeed - 10 Nov 2008
Stryker Announces Organizational and Leadership Changes
Devices Personnel
 HSMN NewsFeed - 8 Oct 2008
deCODE Launches deCODE BreastCancer(TM), a Genetic Test to Screen for Risk of the Most Common Forms of Breast Cancer
Diagnostics Oncology
 HSMN NewsFeed - 22 Sep 2008
Toshiba Secures Magnetic Resonance Broadlane Live Group Buy Agreement
Devices Radiology Group Purchasing
 HSMN NewsFeed - 18 Sep 2008
Dr. Michael Beckert Steps Down as EVP and CMO of LifeCycle Pharma Effective December 31, 2008
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Sep 2008
Denosumab Osteoporosis Trial Finds Patients Transitioned from Alendronate (Fosamax(R)) to Denosumab Achieved Significantly Greater Gains in Bone Mineral Density versus Those Continuing on Alendronate
Biopharmaceuticals
 HSMN NewsFeed - 15 Sep 2008
Pfizer Launches New Medicine Safety Website to Help Healthcare Professionals and Patients Make Better Informed Decisions about Treatment Options
Biopharmaceuticals
 HSMN NewsFeed - 9 Sep 2008
Pfizer Will Withdraw Global Marketing Applications for Dalbavancin to Conduct a New Trial
Biopharmaceuticals Regulatory FDA
 HSMN NewsFeed - 9 Sep 2008
Mom with Diabetes Invents Device to Make Insulin Injections Easier
Devices Drug Delivery Endocrinology
 HSMN NewsFeed - 2 Sep 2008
World Renowned ALS Expert From Harvard Medical School and Mass. General Hospital, Dr. Robert H. Brown Jr., Joins BrainStorm Cell Therapeutics Scientific Advisory Board
Regenerative Medicine Personnel
 HSMN NewsFeed - 30 Aug 2008
Is Drug Lifecycle Management the Answer to the $100Billion Question?
Biopharmaceuticals Generics
 HSMN NewsFeed - 26 Aug 2008
Oridion Expands its OEM Partnerships - New Agreement with Spacelabs Healthcare
Devices Monitoring
 HSMN NewsFeed - 25 Aug 2008
TomoTherapy Announces Management Transitions
Devices Personnel
 HSMN NewsFeed - 18 Aug 2008
Kevin Van Bladel Joins BioVentrix as Vice President of Research and Development
Devices Cardiology Personnel
 HSMN NewsFeed - 8 Aug 2008
EXACT Sciences Announces Next Generation Stool-based DNA Technology Study Results of 92% for Colorectal Cancer Detection
Diagnostics Gastroenterology Oncology
 HSMN NewsFeed - 6 Aug 2008
GPC Biotech Reports that Celgene to Terminate Co-Development and License Agreement for Satraplatin
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 23 Jul 2008
Tomas Leanderson appointed new President & CEO for Active Biotech
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jul 2008
Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 Jul 2008
Advanced Bionics Reaches Resolution With FDA, Settles Financial Suit
Devices FDA Litigation
 HSMN NewsFeed - 17 Jul 2008
AMT Appoints Director Global Marketing and Sales
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jul 2008
Bioheart, Inc., Announces Management Change
Regenerative Medicine Personnel
 HSMN NewsFeed - 10 Jul 2008
Angiotech wins before the UK House of Lords
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 8 Jul 2008
Monogram Announces Commercial Availability of the HERmark(TM) Breast Cancer Assay
Diagnostics Oncology
 HSMN NewsFeed - 1 Jul 2008
Clarient Launches New Colorectal Cancer Test
Diagnostics Oncology
 HSMN NewsFeed - 30 Jun 2008
Acusphere Announces FDA Acceptance of Imagify(TM) NDA for Detection of Coronary Artery Disease
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 30 Jun 2008
GlaxoSmithKline Responds to FDA on CERVARIX(R) and Plans to Submit Final Study Data for Approval
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 27 Jun 2008
Wyeth Announces Bernard Poussot Assumes Chairman of the Board Position
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jun 2008
AGA Medical Announces Management Transition
Devices Cardiology Personnel
 HSMN NewsFeed - 16 Jun 2008
3M Discontinues Collaboration with Gen-Probe to Develop Molecular Tests for Healthcare-Associated Infections
Diagnostics
 HSMN NewsFeed - 12 Jun 2008
ORENCIA(R) (abatacept) Provided an Increasing Degree of Inhibition of Structural Damage Through Three Years in Adults with Moderate to Severe Rheumatoid Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 4 Jun 2008
Amgen and Wyeth Statement on the FDA Early Communication About Tumor Necrosis Factor (TNF) Blockers
Biopharmaceuticals
 HSMN NewsFeed - 28 May 2008
Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 May 2008
Endo Pharmaceuticals Appoints Blaine T. Davis as Vice President, Investor Relations and Corporate Communications
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 May 2008
Forbes Medi-Tech Announces Corporate Restructuring
Biopharmaceuticals
 HSMN NewsFeed - 15 May 2008
Medical Action Industries Announces the Nomination of Kenneth W. Davidson to the Board of Directors
Devices Personnel
 HSMN NewsFeed - 14 May 2008
Top Cancer Hospitals in Denmark and Netherlands First in Europe to Treat Patients With RapidArc(TM) Radiotherapy
Devices Oncology
 HSMN NewsFeed - 14 May 2008
Cook Medical Launches EVOLUTION(R)-Shortie Mechanical Dilator Sheath Set for Vessel Access Associated with Lead Extraction
Devices Cardiology
 HSMN NewsFeed - 13 May 2008
Siemens Introduces Dual Energy Applications for General Imaging
Devices Radiology
 HSMN NewsFeed - 29 Apr 2008
Medtronic Announces Organizational and Leadership Changes
Devices Personnel
 HSMN NewsFeed - 25 Apr 2008
Elekta Announces First Linear Accelerator Order in New Zealand
Devices Oncology
 HSMN NewsFeed - 23 Apr 2008
Derma Sciences Announces Agreement With MedAssets for MEDIHONEY(TM) Wound & Burn Dressings
Devices Wound Care Group Purchasing
 HSMN NewsFeed - 23 Apr 2008
Stem Cell Therapy International Amends Merger With Histostem
Regenerative Medicine Mergers & Acquisitions
 HSMN NewsFeed - 18 Apr 2008
VisEn Medical Raises $5.0 Million in Expanded Series B Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 11 Apr 2008
Maria Sainz Named President and CEO of Concentric Medical
Devices Personnel
 HSMN NewsFeed - 11 Apr 2008
Status of the E2007 (perampanel) Development Program - Termination of Parkinson's Disease Clinical Development and Focus on Neuropathic Pain and Epilepsy Indications
Biopharmaceuticals
 HSMN NewsFeed - 10 Apr 2008
MannKind Addresses Pfizer's Announcement Regarding Exubera
Biopharmaceuticals Drug Delivery Endocrinology Oncology
 HSMN NewsFeed - 8 Apr 2008
New York Medicaid Program Establishes Coverage for Trofile(TM)
Diagnostics Biopharmaceuticals HIV/AIDS Reimbursement
 HSMN NewsFeed - 1 Apr 2008
DiagnoCure provides update on operations
Diagnostics
 HSMN NewsFeed - 31 Mar 2008
Phase III Data Showed Taranabant, Merck's Investigational Medicine to Treat Obesity, Led to Statistically Significant Weight Loss
Biopharmaceuticals
 HSMN NewsFeed - 31 Mar 2008
Update on ACHIEVE: A Study of Merck's Investigational Extended-Release Niacin/Laropiprant (CORDAPTIVE(TM))
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 30 Mar 2008
Large Study Gives Nod to Drug-Eluting Stents in Heart Attack
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Mar 2008
Sonus Pharmaceuticals Refines Strategic Initiatives
Biopharmaceuticals
 HSMN NewsFeed - 25 Mar 2008
Monogram Announces Promotion of Gordon Parry, PhD, to Vice President, Research and Development, Oncology
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 24 Mar 2008
BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients
Biopharmaceuticals
 HSMN NewsFeed - 18 Mar 2008
CeraShield(TM) Coated Endotracheal Tubes Provide up to 21 Days of Protection against Bacterial Colonization in Preclinical Testing
Devices
 HSMN NewsFeed - 17 Mar 2008
FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Mar 2008
Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs
Biopharmaceuticals
 HSMN NewsFeed - 10 Mar 2008
Curis Announces Conclusion of Hedgehog Agonist Collaboration with Wyeth
Biopharmaceuticals
 HSMN NewsFeed - 8 Mar 2008
Controversial Shoulder Surgery for First-time Dislocation Proven Effective Long-Term
Orthopaedic
 HSMN NewsFeed - 6 Mar 2008
Bausch & Lomb Names Paul H. Sartori Corporate Vice President and Chief Human Resources Officer
Devices Ophthalmology Personnel
 HSMN NewsFeed - 6 Mar 2008
Colorectal Cancer Screening Guidelines Released by the American Cancer Society Include EXACT Sciences' Stool DNA Technology
Diagnostics Oncology
 HSMN NewsFeed - 4 Mar 2008
Cardinal Health Agrees to Acquire ChloraPrep(R) Manufacturer for $490 Million
Devices Mergers & Acquisitions
 HSMN NewsFeed - 28 Feb 2008
Baxter to Proceed With Recall of Remaining Heparin Sodium Vial Products
Biopharmaceuticals Product Recall
 HSMN NewsFeed - 26 Feb 2008
Statement of Robert Jarvik, MD, President and CEO of Jarvik Heart, Inc. Regarding the Lipitor DTC Advertisements
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 25 Feb 2008
GPC Biotech Announces Corporate Restructuring and Provides Pipeline Update
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 25 Feb 2008
Teva Announces Two Court Decisions to Revoke MSD's European Patent on Generic Fosamax(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 19 Feb 2008
Cardiovascular Sciences, Inc. Consolidates Progress and Forges Ahead
Devices Personnel
 HSMN NewsFeed - 7 Feb 2008
EMEA Accepts for Review Vidaza(R) Marketing Authorization Application for Higher-Risk Myelodysplastic Syndromes
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 5 Feb 2008
STERIS Corporation Promotes Timothy L. Chapman to Group President of Healthcare
Devices Personnel
 HSMN NewsFeed - 25 Jan 2008
Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
Biopharmaceuticals
 HSMN NewsFeed - 25 Jan 2008
Merck and Schering-Plough Respond To Issues Raised About ENHANCE Clinical Trial
Biopharmaceuticals
 HSMN NewsFeed - 19 Jan 2008
GSK Does Not Option XL784 for Further Development
Biopharmaceuticals Licensing
 HSMN NewsFeed - 18 Jan 2008
In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
Biopharmaceuticals
 HSMN NewsFeed - 18 Jan 2008
EXACT Sciences Schedules Meeting with CMS to Discuss Application for National Coverage of Stool-based DNA Colorectal Cancer Screening
Diagnostics Oncology Reimbursement
 HSMN NewsFeed - 11 Jan 2008
Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM)
Biopharmaceuticals
 HSMN NewsFeed - 7 Jan 2008
Penumbra, Inc. Announces 510(k) Clearance of the Penumbra System(TM) for Use in the Revascularization of Patients With Acute Ischemic Stroke
Devices Neurology Interventional FDA
 HSMN NewsFeed - 25 Dec 2007
Breast Cancer Gene Mutation More Common in Hispanic, Young Black Women, Stanford/NCCC Study Finds
Oncology
 HSMN NewsFeed - 13 Dec 2007
NeoGuide Systems Refocuses Its Business on Natural Orifice Transluminal Endoscopic Surgery Market
Devices Surgery
 HSMN NewsFeed - 9 Dec 2007
REVLIMID(R) (Lenalidomide) Plus Low-Dose Dexamethasone Achieves Unprecedented Survival Rate in ECOG Phase III Trial in Newly Diagnosed Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Dec 2007
BioCryst Provides Forodesine HCl Update
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Dec 2007
Amarin Signs Agreement to Acquire Ester Neurosciences
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 5 Dec 2007
DiagnoCure establishes U.S. commercial operations - Lease signed on service laboratory and key directors hired
Diagnostics Personnel
 HSMN NewsFeed - 4 Dec 2007
ThromboGenics Presents Results of the Vitreomacular Traction Trial (MIVI IIT) at the American Society of Retina Specialists Annual Meeting
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 30 Nov 2007
Health Canada Approves Conceptus' Third Generation Essure(R) Permanent Birth Control System
Devices Regulatory
 HSMN NewsFeed - 26 Nov 2007
TeraRecon Appoints New President
Devices Radiology Personnel
 HSMN NewsFeed - 23 Nov 2007
Bristol-Myers Squibb and Pierre Fabre Provide Update On Vinflunine Development Status
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 20 Nov 2007
Merck/Schering-Plough Pharmaceuticals Provides Update on ENHANCE Trial
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 12 Nov 2007
PAION is Seeking a New US-Partner for Desmoteplase
Biopharmaceuticals Neurology
 HSMN NewsFeed - 9 Nov 2007
Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate
Biopharmaceuticals
 HSMN NewsFeed - 7 Nov 2007
Monogram Obtains Coverage for Trofile(TM) Assay from California ADAP Program
Diagnostics Reimbursement HIV/AIDS
 HSMN NewsFeed - 6 Nov 2007
Gilead and LG Life Sciences Announce Global License Agreement to Advance Novel Drug Candidates for Treatment of Fibrotic Diseases
Biopharmaceuticals Licensing
 HSMN NewsFeed - 2 Nov 2007
Ninety-one Percent of BARACLUDE(R) (entecavir) Treated Patients in a Four-Year Cohort Demonstrated Virologic Suppression to Undetectable Levels
Biopharmaceuticals
 HSMN NewsFeed - 1 Nov 2007
New Studies Unveiled at ASTRO's 49th Annual Meeting of Radiation Oncology Specialists Support the Effectiveness of IsoRay Medical's Proxcelan(TM) for the Treatment of Prostate Cancer
Devices Oncology
 HSMN NewsFeed - 1 Nov 2007
OccuLogix Suspends RHEO(TM) System Clinical Development Program
Devices Ophthalmology
 HSMN NewsFeed - 30 Oct 2007
Diomed Comments on Pretrial Motions in VNUS Litigation
Devices Litigation
 HSMN NewsFeed - 29 Oct 2007
Thallion Provides Update on Shigamabs(R) Clinical Development and U.S. Regulatory Plan
Biopharmaceuticals
 HSMN NewsFeed - 29 Oct 2007
Jerini Submits New Drug Application for Icatibant in the Treatment of HAE to the FDA and Requests Priority Review
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Oct 2007
IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
Devices Oncology
 HSMN NewsFeed - 26 Oct 2007
Orexo to Acquire Biolipox - Update
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Oct 2007
Kensey Nash Reaches Agreement with Ramius on New Board Nominees
Devices Interventional Orthopaedic Personnel
 HSMN NewsFeed - 24 Oct 2007
Liver Health Improves after Bariatric Surgery
Surgery
 HSMN NewsFeed - 23 Oct 2007
Diomed Responds to VNUS Patent Litigation Trial Delay and Summary Judgment Motion Ruling
Devices Litigation
 HSMN NewsFeed - 18 Oct 2007
Lilly and MacroGenics Announce Licensing and Collaboration Agreement
Biopharmaceuticals Licensing
 HSMN NewsFeed - 16 Oct 2007
FDA Advisory Committee Votes in Favor of Earlier Use of Phosphate Binders in Stage 4 Kidney Disease Patients With Hyperphosphatemia
Biopharmaceuticals
 HSMN NewsFeed - 16 Oct 2007
Zimmer's Offer To Acquire ORTHOsoft Is Successful
Devices Surgery Orthopaedic Mergers & Acquisitions
 HSMN NewsFeed - 15 Oct 2007
Wyeth to Appeal Nevada Hormone Therapy Trial Verdict
Biopharmaceuticals Litigation
 HSMN NewsFeed - 15 Oct 2007
Biopure Announces Expanded Clinical Program To Target Anemia
Biopharmaceuticals
 HSMN NewsFeed - 9 Oct 2007
ThermoGenesis Announces 510(k) Clearance for AutoXpress(TM) Cord Blood Processing System
Devices Regenerative Medicine FDA
 HSMN NewsFeed - 3 Oct 2007
VNUS Medical's Patent Lawsuit Against Laser Competitors to Proceed to Trial
Devices Litigation
 HSMN NewsFeed - 1 Oct 2007
PDL BioPharma to Actively Seek Sale of Entire Company or Its Key Assets
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Sep 2007
ISTA Pharmaceuticals Expands Its Pipeline in Allergy Treatments
Biopharmaceuticals Licensing
 HSMN NewsFeed - 24 Sep 2007
Inflazyme Pharmaceuticals Signs Asset Sale Agreement With Biolipox for a Potential Value of up to $11 Million, Plus a Potential Royalty Payment
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Sep 2007
CytRx Provides Arimoclomol and Iroxanadine Clinical Trial Updates
Biopharmaceuticals Neurology Wound Care
 HSMN NewsFeed - 12 Sep 2007
GeoPharma, Inc. Provides Update on Recent Corporate Developments
Biopharmaceuticals
 HSMN NewsFeed - 10 Sep 2007
Aspreva Provides Update On Lupus Nephritis Development Program
Biopharmaceuticals
 HSMN NewsFeed - 6 Sep 2007
New Jersey High Court Denies Nationwide Class-Action Status to Insurance Companies Seeking VIOXX(R) Reimbursements
Biopharmaceuticals Litigation
 HSMN NewsFeed - 31 Aug 2007
Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
Biopharmaceuticals
 HSMN NewsFeed - 28 Aug 2007
PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development
Biopharmaceuticals
 HSMN NewsFeed - 23 Aug 2007
GlaxoSmithKline Accelerates Review of Exelixis' XL880
Biopharmaceuticals
 HSMN NewsFeed - 20 Aug 2007
SonoSite Amends Patent Infringement Lawsuit against GE with Additional Counterclaims
Devices Litigation
 HSMN NewsFeed - 16 Aug 2007
Bioniche Provides Update on Refractory Bladder Cancer Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Aug 2007
Myriad Genetics Initiates Phase 2 Clinical Trial of Azixa in Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Aug 2007
European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreich's Ataxia by Santhera
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 14 Aug 2007
Zila Takes Steps to Restructure Its Business
Devices Oncology
 HSMN NewsFeed - 9 Aug 2007
Leading Medical Centers Join Growing Number of Locations Offering IsoRay's Prostate Cancer Treatment Proxcelan(TM) Brachytherapy Seeds (Cesium-131)
Devices Oncology
 HSMN NewsFeed - 8 Aug 2007
Neuromed Announces that Merck & Co., Inc. Discontinues Development of Pain Drug Candidate, Joint Research Program Continues
Biopharmaceuticals
 HSMN NewsFeed - 7 Aug 2007
ORENCIA(R) (abatacept) Supplemental Biologics License Application for Juvenile Idiopathic Arthritis Accepted by FDA for Filing and Review
Biopharmaceuticals FDA
Return to NewsFeed  

 Additional items found! 463

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 463 additional stories matching:
DeCIDe
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!